Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development
Jeffrey M. Axten, Stuart P. Romeril, Arthur Y. L. Shu et al. · ACS Medicinal Chemistry Letters · 2013
We recently reported the discovery of GSK2606414 (1), a selective first in class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), which inhibited PERK activation in cells and demonstrated tumor growth inhibition in a human tumor xenograft in mice. In continuation of our drug discovery program, we applied a strategy to decrease inhibitor lipophilicity as a means to improve physical properties and pharmacokinetics. This report describes our medicinal chemistry optimization culminating in the discovery of the PERK inhibitor GSK2656157 (6), which was selected for advancement to preclinical development.
Cited by 232 works. doi:10.1021/ml400228e
Authors
- Jeffrey M. Axten
- Stuart P. Romeril
- Arthur Y. L. Shu
- Jeffrey M. Ralph
- Jesús R. Medina
- Yanhong Feng
- William Hoi Hong Li
- Seth W. Grant
- Dirk A. Heerding
- Elisabeth A. Minthorn
- Thomas Mencken
- Nathan Gaul
- Aaron S. Goetz
- Thomas B. Stanley
- Annie M. Hassell
- Robert T. Gampe
- Charity L. Atkins
- Rakesh Kumar
References
- Fluorine in Pharmaceuticals: Looking Beyond Intuition
- Signal integration in the endoplasmic reticulum unfolded protein response
- Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- Diabetes Mellitus and Exocrine Pancreatic Dysfunction in Perk−/− Mice Reveals a Role for Translational Control in Secretory Cell Survival
- Identification and Characterization of Pancreatic Eukaryotic Initiation Factor 2 α-Subunit Kinase, PEK, Involved in Translational Control
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- The PERK Eukaryotic Initiation Factor 2α Kinase Is Required for the Development of the Skeletal System, Postnatal Growth, and the Function and Viability of the Pancreas
- ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
- The role of fluorine in medicinal chemistry